Msm (Methylsulfonylmethane) for Anti-Inflammatory

Research suggests that MSM may have anti-inflammatory properties, with at least one 2024 computational and laboratory study indicating that MSM can interact with sphingosine kinase 1, an enzyme involved in inflammatory and cancer-related pathways. That study found MSM reduced the viability of glioma cells in laboratory conditions and appeared to trigger programmed cell death, pointing to a possible mechanism through which its anti-inflammatory effects might operate. However, the available evidence on this specific mechanism is limited to early-stage in silico and in vitro work, meaning findings have not yet been confirmed in animal models or human clinical trials. Readers should keep in mind that laboratory results do not always translate to effects in the human body, and a broader body of clinical research would be needed before firm conclusions can be drawn about MSM's anti-inflammatory efficacy.